Menu
Log in
Log in

ISDE News

  • 18 Feb 2018 9:25 AM | ISDE Membership (Administrator)

    There have been multiple new guidelines published for the diagnosis and management of eosinophilic esophagitis. This study by Vermeulen et al utilizes a population based, multicenter database to evaluate variations in the routine clinical practice of eosinophilic esophagitis. Despite the publications of several guidelines on this field, there continues to be significant practice variation.

    Read full abstract here

  • 13 Feb 2018 3:07 AM | Anonymous

    The International Society for Diseases of the Esophagus (ISDE) is pleased to announce that it is now accepting applications to host the ISDE 2022 World Congress.

    Click here for more information.


  • 31 Jan 2018 8:44 AM | Anonymous

    click on the picture below to watch the video.



  • 30 Jan 2018 9:27 AM | ISDE Membership (Administrator)

    Eosinophilic esophagitis continues to be increasingly recognized in the adult population.  However there remains little data regarding modifiable risk factors for this condition.  This study by Koutlas et al explores modifiable risk factors for eosinophilic esophagitis and their impact on disease manifestation and treatment.  

    Read full abstract here. 

  • 19 Dec 2017 7:37 AM | Anonymous

    click here to watch

  • 14 Dec 2017 7:31 PM | ISDE Membership (Administrator)


    The final Esophagram for 2017 is now available. Check it out here


  • 13 Dec 2017 7:16 PM | ISDE Membership (Administrator)

    On Dec 8 - 9 Dr. Mark Ferguson & Dr. Donald Low attended a training session in Shanghai with 10 participating Chinese centers.


  • 12 Dec 2017 4:42 AM | Anonymous

    (click on the image below to watch the video)


  • 11 Dec 2017 9:29 AM | ISDE Membership (Administrator)

    Neoadjuvant radiochemotherapy based on the CROSS regimen is now widely adopted as the standard of care for esophageal cancer; with this regimen nearly half of patients with squamous cell carcinoma and 20% to 30% of patients with adenocarcinoma will have a complete pathological response (pCR), raising the question if an esophageal resection is still indicated in such patients. The article “Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer”1 reviews the current literature on this topic: four retrospective studies only were individuated, all of them consistently showing that the survival rate did not differ after clinical CR between those operated on and those left in an active surveillance program. However, the majority of patients who did not received surgery were unfit or refused it. Two RCTs (ESOSTRATE in France and SANO –Surgery As Needed for Oesophageal cancer- have now been initiated and both expect reseults in 2023.

    1. Noordman BJ, Wijnhoven BPL, Lagarde SM, Biermann K et al. Diseases of The Esophagus 2017; December Issue

    Read the full abstract here

    How to manage an esophageal leak due to spontaneous (Boherhave) or iatrogenic perforation or after esophageal anastomosis remains a controversial topic. In this article “Outcome following the main treatment options in patients with a leaking esophagus: a systematic literature review2 the Authors perform a systematic review to compare the two most used treatments: insertion of a self expandable metal stent and surgical repair. From 2005 to 2015 they selected 17 articles for a total of 371 patients treated with SEMS and 368 treated with direct or reinforced suture. The success rate was similar (88% vs 83%) with an in-hospital mortality of 7.5% for SEMS and 17% for surgery, suggesting that SEMS could be safely used to seal an esophageal leak, provided that less than48 hours elapsed from the leak and the positioning of the stent.

    2. Persson S, Fouvelais I, Irino T, Lundell L. Diseases of the Esophagus 2017; December Issue

    Read the full abstract here 

  • 01 Dec 2017 4:28 PM | ISDE Membership (Administrator)

    The ISDE Research & Database Committee had a productive meeting at ESDE 2017 in Utrecht, The Netherlands. Committee members look forward to implementing future plans in 2018. See who the committee members are here.


Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

© International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software